CaptureSelect™ Biotin Anti-AAV9 Conjugate consists of a 13 kDa camelid antibody fragment (affinity ligand) that specifically binds with high affinity to adeno-associated virus particles of serotype 9 (AAV9). The affinity ligand is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligand when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces. This conjugate allows you to detect, quantitate, and characterize AAV9 particles.
Applications for CaptureSelect Biotin Anti-AAV9 Conjugate include ELISA, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).
For Research Use Only. Not for use in diagnostic procedures.